Physician profile
John Krumme
NPI 1689092520
$9,604.41
in general payments reported to CMS, 2019-2025
8 companies · $1,170 in 2025
The $1,170 reported for 2025 was more than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $2,299 · 2022: $3,381 · 2023: $1,323 · 2024: $1,431 · 2025: $1,170.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,431 · Travel and Lodging: $493.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,430.98 |
| Travel and Lodging | $493.05 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $5,817.63 | 2021-2025 | Mako, Aequalis, Actishield |
| Smith+Nephew, INC. | $1,630.48 | 2022-2025 | Redapt, Real Intelligence, Polarstem |
| Zimmer Biomet Holdings, INC. | $1,622.34 | 2022-2025 | Persona, G7, Taperloc |
| Becton, Dickinson and Company | $163.84 | 2022 | |
| Depuy Synthes Sales INC. | $124.95 | 2021-2025 | |
| Onkos Surgical, INC. | $123.29 | 2022-2023 | Eleos Limb Salvage System |
| Bone Support INC. | $99.31 | 2022 | |
| Illuminoss Medical, INC. | $22.57 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Krumme listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.